Header Logo

SARVARI YELLAPRAGADA

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
AddressOne Baylor Plaza
Houston, TX 77030
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Inchaustegui C, Yellapragada S, Badawy J, Ahmed A, White A, Sargsyan Z. Dyspneic and pink. J Hosp Med. 2024 Apr 02. PMID: 38563412.
      Citations:    Fields:    
    2. Nguyen TM, Amenta E, Chapman L, Yellapragada S, Krishnan B, Lim J, Hamill RJ. Ibrutinib-associated cutaneous mucormycosis due to an Apophysomyces species: report of a case and review of the literature. Ther Adv Infect Dis. 2024 Jan-Dec; 11:20499361241241199. PMID: 38545450; PMCID: PMC10966995.
      Citations:    
    3. Cay G, Sada YH, Dehghan Rouzi M, Uddin Atique MM, Rodriguez N, Azarian M, Finco MG, Yellapragada S, Najafi B. Harnessing physical activity monitoring and digital biomarkers of frailty from pendant based wearables to predict chemotherapy resilience in veterans with cancer. Sci Rep. 2024 01 31; 14(1):2612. PMID: 38297103; PMCID: PMC10831115.
      Citations:    Fields:    Translation:Humans
    4. DuMontier C, La J, Bihn J, Corrigan J, Yildirim C, Dharne M, Hassan H, Yellapragada S, Abel GA, Gaziano JM, Do NV, Brophy M, Kim DH, Munshi NC, Fillmore NR, Driver JA. More intensive therapy as more effective treatment for frail patients with multiple myeloma [corrected]. Blood Adv. 2023 10 24; 7(20):6275-6284. PMID: 37582048; PMCID: PMC10589796.
      Citations:    Fields:    Translation:Humans
    5. Hussain M, Yellapragada S, Al Hadidi S. Differential Diagnosis and Therapeutic Advances in Multiple Myeloma: A Review Article. Blood Lymphat Cancer. 2023; 13:33-57. PMID: 37731771; PMCID: PMC10508231.
      Citations:    
    6. Friedman DR, Rodgers TD, Kovalick C, Yellapragada S, Szumita L, Weiss ES, Friedman DR. Veterans with blood cancers: Clinical trial navigation and the challenge of rurality. J Rural Health. 2024 Jan; 40(1):114-120. PMID: 37389421.
      Citations:    Fields:    Translation:Humans
    7. Maneix L, Iakova P, Moree SE, Hsu JI, Mistry RM, Stossi F, Lulla P, Sun Z, Sahin E, Yellapragada SV, Catic A. Proteasome Inhibitors Silence Oncogenes in Multiple Myeloma through Localized Histone Deacetylase 3 (HDAC3) Stabilization and Chromatin Condensation. Cancer Res Commun. 2022 12; 2(12):1693-1710. PMID: 36846090; PMCID: PMC9949381.
      Citations:    Translation:HumansCells
    8. Khan S, Alam ST, Ramos RT, Mbue JE, Apostolidou E, Rivero GA, Yellapragada SV. Luspatercept in Low-Risk Myelodysplastic Syndrome: A Real-World Single Institution Case Series. Clin Hematol Int. 2022 Aug 23. PMID: 35997953.
      Citations:    
    9. Alam ST, Dongarwar D, Lopez E, Yellapragada S, Rivero G, Huang Q, Miler-Chism C, Mims M, Salihu HM. Disparities in mortality among acute myeloid leukemia-related hospitalizations. Cancer Med. 2023 02; 12(3):3387-3394. PMID: 35924430; PMCID: PMC9939120.
      Citations:    
    10. Khan S, Premji S, Huang Q, Verstovsek G, Bushan S, Yellapragada SV. An eye-catching atypical illustration of the evaluation and management of AL amyloidosis secondary to myeloma. Clin Case Rep. 2021 Dec; 9(12):e05176. PMID: 34938552; PMCID: PMC8659555.
      Citations:    
    11. Al Hadidi S, Yellapragada S. Treatment Options for Relapsed and Refractory Multiple Myeloma: A Luxury or a Challenge? JAMA Oncol. 2021 10 01; 7(10):1449-1450. PMID: 34383000.
      Citations:    Fields:    Translation:Humans
    12. Fillmore NR, Cirstea D, Munjuluri A, Yameen H, Yellapragada SV, Do NV, Brophy MT, Szalat RE, Munshi NC. Lack of differential impact of del17p on survival in African Americans compared with White patients with multiple myeloma: a VA study. Blood Adv. 2021 09 28; 5(18):3511-3514. PMID: 34428278; PMCID: PMC8945588.
      Citations:    Fields:    Translation:Humans
    13. Fillmore NR, DuMontier C, Yildirim C, La J, Epstein MM, Cheng D, Cirstea D, Yellapragada S, Abel GA, Gaziano JM, Do N, Brophy M, Kim DH, Munshi NC, Driver JA. Defining Multimorbidity and Its Impact in Older United States Veterans Newly Treated for Multiple Myeloma. J Natl Cancer Inst. 2021 08 02; 113(8):1084-1093. PMID: 33523236; PMCID: PMC8328982.
      Citations: 2     Fields:    Translation:Humans
    14. DuMontier C, Fillmore NR, Yildirim C, Cheng D, La J, Orkaby AR, Charest B, Cirstea D, Yellapragada S, Gaziano JM, Do N, Brophy MT, Kim DH, Munshi NC, Driver JA. Contemporary Analysis of Electronic Frailty Measurement in Older Adults with Multiple Myeloma Treated in the National US Veterans Affairs Healthcare System. Cancers (Basel). 2021 Jun 18; 13(12). PMID: 34207459; PMCID: PMC8233717.
      Citations: 2     
    15. Kang GE, Murphy TK, Kunik ME, Badr HJ, Workeneh BT, Yellapragada SV, Sada YH, Najafi B. The detrimental association between fear of falling and motor performance in older cancer patients with chemotherapy-induced peripheral neuropathy. Gait Posture. 2021 07; 88:161-166. PMID: 34091147; PMCID: PMC8316411.
      Citations: 2     Fields:    Translation:Humans
    16. Maneix L, Sweeney MA, Lee S, Iakova P, Moree SE, Sahin E, Lulla P, Yellapragada SV, Tsai FTF, Catic A. The Mitochondrial Protease LonP1 Promotes Proteasome Inhibitor Resistance in Multiple Myeloma. Cancers (Basel). 2021 Feb 17; 13(4). PMID: 33671345; PMCID: PMC7922145.
      Citations: 2     
    17. Nguyen CB, Li M, Verstovsek G, Sen U, Swierenga C, Huang Q, Rivero G, Yellapragada SV. Primary bone lymphoma of the ilium successfully treated without radiation. Clin Case Rep. 2020 Dec; 8(12):3130-3133. PMID: 33363894; PMCID: PMC7752449.
      Citations:    
    18. Yellapragada SV, Fillmore NR, Frolov A, Zhou Y, Dev P, Yameen H, Ifeorah C, Do NV, Brophy MT, Munshi NC. Vitamin D deficiency predicts for poor overall survival in white but not African American patients with multiple myeloma. Blood Adv. 2020 04 28; 4(8):1643-1646. PMID: 32315398; PMCID: PMC7189302.
      Citations: 7     Fields:    Translation:Humans
    19. Fillmore NR, Yellapragada SV, Ifeorah C, Mehta A, Cirstea D, White PS, Rivero G, Zimolzak A, Pyarajan S, Do N, Brophy M, Munshi NC. With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study. Blood. 2019 06 13; 133(24):2615-2618. PMID: 31003998; PMCID: PMC6566591.
      Citations: 27     Fields:    Translation:Humans
    20. Zahiri M, Chen KM, Zhou H, Nguyen H, Workeneh BT, Yellapragada SV, Sada YH, Schwenk M, Najafi B. Using wearables to screen motor performance deterioration because of cancer and chemotherapy-induced peripheral neuropathy (CIPN) in adults - Toward an early diagnosis of CIPN. J Geriatr Oncol. 2019 11; 10(6):960-967. PMID: 30665876; PMCID: PMC6639160.
      Citations: 15     Fields:    Translation:Humans
    21. Chang E, Sabichi AL, Kramer JR, Hartman C, Royse KE, White DL, Patel NR, Richardson P, Yellapragada SV, Garcia JM, Chiao EY. Nivolumab Treatment for Cancers in the HIV-infected Population. J Immunother. 2018 Oct; 41(8):379-383. PMID: 30020193; PMCID: PMC6128753.
      Citations: 10     Fields:    Translation:Humans
    22. Chang E, Rivero G, Patel NR, Chiao EY, Lai S, Bajaj K, Mbue JE, Yellapragada SV. HIV-related Refractory Hodgkin Lymphoma: A Case Report of Complete Response to Nivolumab. Clin Lymphoma Myeloma Leuk. 2018 02; 18(2):e143-e146. PMID: 29342442; PMCID: PMC5809264.
      Citations: 8     Fields:    Translation:Humans
    23. Chang E, Rivero G, Jiang B, Yellapragada S, Thiagarajan P. Gelatinous Marrow Transformation Associated with Imatinib: Case Report and Literature Review. Case Rep Hematol. 2017; 2017:1950724. PMID: 28133556; PMCID: PMC5241459.
      Citations: 1     
    24. Li A, Yellapragada SV, Mims M, Frolov A, Rivero GA. Significant improvement in overall survival among patients diagnosed with low-risk myelodysplastic syndrome treated with selective serotonin reuptake inhibitors. Br J Haematol. 2017 04; 177(1):142-144. PMID: 27061100.
      Citations:    Fields:    Translation:Humans
    25. Amini B, Yellapragada S, Shah S, Rohren E, Vikram R. State-of-the-Art Imaging and Staging of Plasma Cell Dyscrasias. Radiol Clin North Am. 2016 May; 54(3):581-96. PMID: 27153790.
      Citations: 5     Fields:    Translation:Humans
    26. Molina M, Yellapragada S, Mims M, Rahman E, Rivero G. Pulmonary Complications of Azanucleoside Therapy in Patients with Myelodysplastic Syndrome and Acute Myelogenous Leukemia. Case Rep Hematol. 2015; 2015:357461. PMID: 26798526; PMCID: PMC4698523.
      Citations: 1     
    27. Girnius SK, Lee S, Kambhampati S, Rose MG, Mohiuddin A, Houranieh A, Zimelman A, Grady T, Mehta P, Behler C, Hayes TG, Efebera YA, Prabhala RH, Han A, Yellapragada SV, Klein CE, Roodman GD, Lichtenstein A, Munshi NC. A Phase II trial of weekly bortezomib and dexamethasone in veterans with newly diagnosed multiple myeloma not eligible for or who deferred autologous stem cell transplantation. Br J Haematol. 2015 Apr; 169(1):36-43. PMID: 25572917.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    28. Khalid U, Awar O, Verstovsek G, Cheong B, Yellapragada SV, Jneid H, Deswal A, Virani SS. Case report: isolated cardiac amyloidosis: an enigma unravelled. Methodist Debakey Cardiovasc J. 2015 Jan-Mar; 11(1):53-8. PMID: 25793032; PMCID: PMC4362068.
      Citations: 3     Fields:    Translation:Humans
    29. Nautiyal K, Li R, Yellapragada S, Thiagarajan P, Mims M, Rivero G. Progressive transfusion and growth factor independence with adjuvant sertraline in low risk myelodysplastic syndrome treated with an erythropoiesis stimulating agent and granulocyte-colony stimulating factor. Leuk Res Rep. 2015; 4(1):1-3. PMID: 25709889; PMCID: PMC4327762.
      Citations:    
    30. Albany C, Alva AS, Aparicio AM, Singal R, Yellapragada S, Sonpavde G, Hahn NM. Epigenetics in prostate cancer. Prostate Cancer. 2011; 2011:580318. PMID: 22191037; PMCID: PMC3236424.
      Citations: 28     
    31. Alva AS, Hahn NM, Aparicio AM, Singal R, Yellapragada S, Sonpavde G. Hypomethylating agents for urologic cancers. Future Oncol. 2011 Mar; 7(3):447-63. PMID: 21417907.
      Citations: 4     Fields:    Translation:HumansCells
    32. Guchhait P, Dasgupta SK, Le A, Yellapragada S, Thiagarajan P, L?pez JA. Lactadherin mediates sickle cell adhesion to vascular endothelial cells in flowing blood. Haematologica. 2007 Sep; 92(9):1266-7. PMID: 17768123.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    YELLAPRAGADA's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (99)
    Explore
    _
    Co-Authors (37)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _